Transaction #9380 · Form 4 · 0001193125-25-286448
OPKO HEALTH, INC. · Purchase · Common Stock
OPKO HEALTH, INC. · Transacted November 18, 2025 · Filed November 18, 2025
What does this filing report?
An SEC Form 4 filing for OPKO HEALTH, INC. records a purchase involving Common Stock on November 18, 2025. The reported quantity was 410. The filing date is November 18, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- OPKO HEALTH, INC.
- Company CIK
- 0000944809
- Security type
- Non-derivative
- Acquisition type
- Purchase · Code P
- Quantity acquired
- 410
- Reported price
- 1.245
- Reference value
- 510.45
- Currency
- Currency not specified
- Ownership
- Indirect
- Holdings after transaction
- 214,386,858
- Ownership description
- See Footnote
- SEC acceptance time
- Nov 18, 2025, 5:18 PM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- FROST PHILLIP MD ET AL ↗
CEO & Chairman · Director · 10% owner
CIK 0000898860
- Frost Gamma Investments Trust ↗
10% owner
CIK 0001380896
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
The linked listing is identified separately from other current company listings.
Filing footnotes & remarks
- F1
- The securities are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is also the sole shareholder of Frost-Nevada Corporation. The reporting person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- F2
- These securities are held by Frost Nevada Investments Trust, of which the Reporting Person is the trustee and Frost-Nevada, L.P. is the sole and exclusive beneficiary. The Reporting Person is one of seven limited partners of Frost-Nevada, L.P. and the sole shareholder of Frost-Nevada Corporation, the sole general partner of Frost-Nevada, L.P. The reporting person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.